3D Tissue Models Oncology 2019 Boston
The true utility and translatability of 3D tumor models within drug research
May 7 - 9, 2019, Boston, MA
The 3D Tissue Models Oncology Summit will showcase the impact 3D models are having on IO and Oncology pipelines. 2018’s inaugural event saw over 80 leading scientists from 50+ different model-development and pharmaceutical organizations meet to define core criteria for the use of 3D tumor models. This year, alongside fresh new case studies and speakers, discussions will address open questions to translatability, platform validity, alongside how additive technologies are presenting further opportunities for these models.
During this conference MIMETAS will be represented by John Lowman. Feel free to contact us if you'd like to set up a meeting!